Evidence map›Paper›PMID 40934175›Full record

ArticlePloS one2025

Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health Survey.

Claudia Gaither, Camille Morgan, Rebecca Kirby, Corine Karema, Pierre Gashema, Jenna Zuromski, Samuel J White, Hillary M Topazian, David Giesbrecht, Kyaw Thwai and 9 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Complexity of Infection andmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Haplotype diversity ofFrontiers in parasitology · 2026
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Claudia GaitherInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Camille MorganDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Rebecca KirbyDepartment of Pathology, Brown University, Providence, Rhode Island, United States of America.
Corine KaremaQuality Equity Health Care, Kigali, Rwanda.
Pierre GashemaINES-Ruhengeri, Ruhengeri, Rwanda.
Jenna ZuromskiDepartment of Pathology, Brown University, Providence, Rhode Island, United States of America.
Samuel J WhiteInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Hillary M TopazianMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.ORCID 0000-0001-7824-9605
David GiesbrechtDepartment of Pathology, Brown University, Providence, Rhode Island, United States of America.
Kyaw ThwaiInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Neeva Wernsman YoungDepartment of Pathology, Brown University, Providence, Rhode Island, United States of America.
Varun GoelDepartment of Geography, University of South Carolina, Columbia, South Carolina, United States of America.
Koby BoyterInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Tharcisse MunyanezaNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Claude Mambo MuvunyiRwanda Biomedical Centre, Kigali, Rwanda.
Jean De Dieu ButeraNational Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
Jeffrey A BaileyDepartment of Pathology, Brown University, Providence, Rhode Island, United States of America.
Jean-Baptiste MazaratiQuality Equity Health Care, Kigali, Rwanda.
Jonathan J JulianoInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.ORCID 0000-0002-0591-0850

Funding

Artemisinin Resistance in Africa: its emergence and evolution in RwandaR01AI156267 · NIAID · BROWN UNIVERSITY · PI BAILEY, JEFFREY A., JULIANO, JONATHAN J · 2021 to 2024
$3.0M
Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
Spatial and molecular epidemiology of hepatitis B transmission in the Democratic Republic of the CongoF30AI169752 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Camille Morgan · 2022 to 2026
$200k
NIAID NIH HHS F30 AI169752NIAID NIH HHS K24 AI134990NIAID NIH HHS R01 AI156267
6 · The paper itself

Abstract

backgroundRecent molecular surveillance suggests an unexpectedly high prevalence of non-falciparum malaria in Africa. Malaria control is also challenged by undetected asymptomatic P. falciparum malaria resulting in an undetectable reservoir for potential transmission. Context-specific surveillance of asymptomatic P. falciparum and non-falciparum species is needed to properly inform malaria control programs.

methodsWe performed quantitative real time PCR for four malaria species in 5,050 primarily adult individuals in Rwanda using the 2014-2015 Demographic Health Survey. We assessed correlates of infection by species to explore attributes associated with each species. Asymptomatic P. ovale spp., P. malariae, and P. falciparum malaria infection had broad spatial distribution across Rwanda. P. vivax infection was rare.

resultsOverall infection prevalence was 22.3% (95%CI [20.3, 24.3]), with P. falciparum and non-falciparum at 16.3% [14.5, 18.1] and 8.0% [6.6, 9.3], respectively. Parasitemias tended to be low and mixed species infections were common, especially where malaria transmission and overall prevalence was the highest. P. falciparum infection was associated with lower wealth, rural residence and low elevation. Fewer factors were significantly associated with non-falciparum malaria.

conclusionsAsymptomatic non-falciparum malaria and P. falciparum malaria are common and widely distributed across Rwanda in adults. Continued molecular monitoring, preferably done by the national malaria control program, of Plasmodium diversity using routine survey samples is needed to strengthen malaria control.

Indexed as

MalariaMalaria, FalciparumAdolescentAdultFemaleHealth SurveysHumansMaleMiddle AgedPlasmodium falciparumPlasmodium ovalePrevalenceRwandaYoung Adult

Identifiers

PMID40934175
PMCPMC12425214

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.